Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
24.16
+0.71 (3.03%)
At close: Apr 28, 2026, 4:00 PM EDT
24.20
+0.04 (0.17%)
After-hours: Apr 28, 2026, 6:48 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 44 employees as of December 31, 2025. The number of employees increased by 13 or 41.94% compared to the previous year.
Employees
44
Change (1Y)
13
Growth (1Y)
41.94%
Revenue / Employee
$1,817,045
Profits / Employee
-$104,568
Market Cap
659.19M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Kamada | 462 |
| Esperion Therapeutics | 294 |
ETON News
- 1 day ago - Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 - GlobeNewsWire
- 12 days ago - Eton Pharmaceuticals Announces CFO Succession Plan - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution - GlobeNewsWire
- 2 months ago - US FDA approves Eton Pharma's hormonal disorder drug - Reuters
- 2 months ago - Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution - GlobeNewsWire